Skip to main content
Figure 2 | BMC Pulmonary Medicine

Figure 2

From: Cisplatin sensitivity is enhanced in non-small cell lung cancer cells by regulating epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2

Figure 2

GC7 enhanced cisplatin sensitivity of mesenchymal NSCLC cells; epithelial NSCLC cells showed greatest sensitivity to cisplatin. (A–C) GC7 enhances NSCLC cell sensitivity to cisplatin. (D–E) A549 and NCI-H1299 express different levels of EMT marker proteins, E-cadherin and vimentin.

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us